Related references
Note: Only part of the references are listed.Synbiotics and probiotics in the critically ill after the PROPATRIA trial
Lee E. Morrow et al.
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2012)
Antibiotic Therapy in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
Khurram J. Khan et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
Comparative genomics of Escherichia coli isolated from patients with inflammatory bowel disease
Rebecca Munk Vejborg et al.
BMC GENOMICS (2011)
Treatment of Inflammatory Bowel Disease Associated E. coli with Ciprofloxacin and E. coli Nissle in the Streptomycin-Treated Mouse Intestine
Andreas Munk Petersen et al.
PLOS ONE (2011)
Clinical trial: probiotic treatment of acute distal ulcerative colitis with rectally administered Escherichia coli Nissle 1917 (EcN)
Harald Matthes et al.
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE (2010)
Survival of the Probiotic Escherichia coli Nissle 1917 (EcN) in the Gastrointestinal Tract Given in Combination with Oral Mesalamine to Healthy Volunteers
Thai Hoa Joeres-Nguyen-Xuan et al.
INFLAMMATORY BOWEL DISEASES (2010)
Sever Sepsis After Probiotic Treatment With Escherichia coli NISSLE 1917
Katrin Guenther et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2010)
A phylogenetic group of Escherichia coli associated with active left-sided Inflammatory Bowel Disease
Andreas M. Petersen et al.
BMC MICROBIOLOGY (2009)
Precolonized Human Commensal Escherichia coli Strains Serve as a Barrier to E-coli O157:H7 Growth in the Streptomycin-Treated Mouse Intestine
Mary P. Leatham et al.
INFECTION AND IMMUNITY (2009)
Probiotic Escherichia coli Nissle 1917 (EcN) for Successful Remission Maintenance of Ulcerative Colitis in Children and Adolescents: an Open-Label Pilot Study
J. Henker et al.
ZEITSCHRIFT FUR GASTROENTEROLOGIE (2008)
High prevalence of Escherichia coli belonging to the B2+D phylogenetic group in inflammatory bowel disease
Roman Kotlowski et al.
GUT (2007)
Analysis of the genome structure of the nonpathogenic probiotic Escherichia coli strain Nissle 1917
L Grozdanov et al.
JOURNAL OF BACTERIOLOGY (2004)
Enhanced Escherichia coli adherence and invasion in Crohn's disease and colon cancer
HM Martin et al.
GASTROENTEROLOGY (2004)
Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine
W Kruis et al.
GUT (2004)
Share Paper
